Location History:
- Toyonaka, JP (2000)
- Osaka, JP (2001)
Company Filing History:
Years Active: 2000-2001
Title: Hisao Kasuga: Innovator in Transgenic Animal Models
Introduction
Hisao Kasuga is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical research through his innovative work in transgenic animal models. His inventions have the potential to advance our understanding of various diseases and aid in the development of therapeutic modalities.
Latest Patents
Hisao Kasuga holds 2 patents, with his latest inventions focusing on transgenic animals that serve as models for various diseases. One of his notable patents is for the 25-hydroxyvitamin D3 24-hydroylase transgenic rats. This transgenic animal can be utilized as a model for renal disease, bone disease, joint disease, pulmonary disease, hyperlipidemia, arteriosclerosis, cardiac disease, diabetes, obesity, digestive organ disease, infectious disease, allergic disease, endocrine disease, dementia, or cancer, along with their complications. This invention provides a nonhuman transgenic mammal that can help unravel the mechanisms of these diseases, explore therapeutic modalities, and screen candidate therapeutic drugs.
Another significant patent is for the monocyte chemoattractant protein and its receptor transgenic animal. This invention introduces an exogenous gene or a mutant gene of a monocyte chemoattractant protein and/or its receptor into a non-human animal. These transgenic animals can be used as pathological models for heart diseases, respiratory diseases, joint diseases, kidney diseases, arteriosclerosis, psoriasis, hyperlipidemia, allergic diseases, bone diseases, blood diseases, cerebrovascular disorders, traumatic cerebral disorders, infectious diseases, dementia, or chronic inflammatory diseases. This allows for the elucidation of the mechanisms of pathogenesis, determination of therapies, and screening for candidate compounds for therapeutic drug development.
Career Highlights
Hisao Kasuga is associated with Takeda Chemical Industries, Inc., where he continues to contribute to groundbreaking research in the field of transgenic models. His work has garnered attention for its potential impact on understanding complex diseases and developing new treatments.
Collaborations
He has collaborated with notable colleagues, including Masami Isaka and Takahito Kitayoshi, to further advance research in his field. Their combined expertise has led to significant advancements in the understanding of disease mechanisms.
Conclusion
Hisao Kasuga's innovative work in transgenic animal models